5379 篇
13902 篇
477809 篇
16280 篇
11761 篇
3926 篇
6532 篇
1251 篇
75594 篇
37748 篇
12156 篇
1656 篇
2859 篇
3418 篇
641 篇
1240 篇
1973 篇
4916 篇
3871 篇
5467 篇
土耳其制药和医疗保健行业报告(2018-2019年)
Turkey Pharma and Healthcare Sector Report 2018-2019
Turkey has the youngest population in Europe, with an estimated median age of 30.9 years in 2017. That is slightly above the median age of the world’s population (30.4 years) but below the EU’s median age of 42.9 years. The crude death rate in Turkey, at 5.8 per 1,000 population in 2016, is below the average of 5.0 for the Middle East and North Africa (MENA) but well above the world and EU averages of 7.6 and 10 respectively. Government efforts to expand the quality and availability of healthcare mean that Turkey has experienced the largest gain in life expectancy at birth of any country in the world since 1970, according to OECD data. Life expectancy increased to 75.8 years in 2016, from 65.3 years in 1992. The county has set a target for life expectancy to be 85 years by 2023, when it will celebrate the 100th anniversary of its foundation as a republic.
01 EXECUTIVE SUMMARY
02 SECTOR IN FOCUS
03 COMPETITIVE LANDSCAPE
04 COMPANIES IN FOCUS
05 REGULATORY ENVIRONMENT
06 HEALTHCARE SERVICES
07 PHARMACEUTICALS
08 MEDICAL DEVICES